Register entry

IDT Biologika GmbH

Registered sites
1
Drug products
2
Live patents
0
Countries
1
Base
Germany
Authorisation

Registered operations

What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.

Analytical testingActive ingredient (API) manufactureLabellingFinished drug manufacturePackagingsterilize
Sites

Facilities

1
SiteLocationOperationsFEI
IDT Biologika GmbHDessau-RosslauGermanyAnalytical testing, Active ingredient (API) manufacture, Labelling, Finished drug manufacture, Packaging, sterilize3005001757
Catalogue

Marketed products

2

Showing 2 of 2.

BrandGeneric nameFormCategory
-talimogene laherparepvecINJECTION, SUSPENSIONDRUG FOR FURTHER PROCESSING
-talimogene laherparepvecINJECTION, SUSPENSIONDRUG FOR FURTHER PROCESSING
Provenance

Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.